SCARSELLI, MARCO Statistiche

SCARSELLI, MARCO  

DIPARTIMENTO DI RICERCA TRASLAZIONALE E DELLE NUOVE TECNOLOGIE IN MEDICINA E CHIRURGIA  

Mostra records
Risultati 1 - 20 di 76 (tempo di esecuzione: 0.025 secondi).
Titolo Data di pubblicazione Autore(i) File
Dopamine-mediated autocrine inhibition of insulin secretion 1-gen-2024 Ferrero, Edoardo; Masini, Matilde; Carli, Marco; Moscato, Stefania; Beffy, Pascale; Vaglini, Francesca; Mattii, Letizia; Corti, Alessandro; Scarselli, Marco; Novelli, Michela; De Tata, Vincenzo
Melanocortin receptor 4 as a new target in melanoma therapy: Anticancer activity of the inhibitor ML00253764 alone and in association with B-raf inhibitor vemurafenib 1-gen-2024 Orlandi, Paola; Banchi, Marta; Vaglini, Francesca; Carli, Marco; Aringhieri, Stefano; Bandini, Arianna; Pardini, Carla; Viaggi, Cristina; Lai, Michele; Alì, Greta; Ottani, Alessandra; Vandini, Eleonora; Guidi, Patrizia; Bernardeschi, Margherita; La Rocca, Veronica; Francia, Giulio; Fontanini, Gabriella; Pistello, Mauro; Frenzilli, Giada; Giuliani, Daniela; Scarselli, Marco; Bocci, Guido
Methadone dose escalation in patients with opioid use disorder and cancer as a strategy for controlling cancer-related pain: A case series 1-gen-2024 Carli, Marco; Fini, Elisabetta; DE LUCA, Giulia; Scarselli, Marco; Lamanna, Francesco; Vico, Tiziana; Bocci, Guido
Optimizing the Time and Dose of Melatonin as a Sleep‐Promoting Drug: A Systematic Review of Randomized Controlled Trials and Dose−Response Meta‐Analysis 1-gen-2024 Cruz‐sanabria, Francy; Bruno, Simone; Crippa, Alessio; Frumento, Paolo; Scarselli, Marco; Skene, Debra J.; Faraguna, Ugo
A 5-Year Study of Antiseizure Medications (ASMs) Monitoring in Patients with Neuropsychiatric Disorders in an Italian Clinical Center 1-gen-2023 Biso, Letizia; Carli, Marco; Kolachalam, Shivakumar; Monticelli, Giorgio; Calabrò, Pasquale Fabio; di Paolo, Antonello; Giorgi, Filippo Sean; Bocci, Guido; Scarselli, Marco
Lithium and Valproic Acid in Bipolar Disorders and Beyond 1-gen-2023 Scarselli, Marco
Melatonin as a Chronobiotic with Sleep-promoting Properties 1-gen-2023 Cruz-Sanabria, Francy; Carmassi, Claudia; Bruno, Simone; Bazzani, Andrea; Carli, Marco; Scarselli, Marco; Faraguna, Ugo
Mesenchymal Stem Cell in Pancreatic Islet Transplantation 1-gen-2023 Barachini, Serena; Biso, Letizia; Kolachalam, Shivakumar; Petrini, Iacopo; Maggio, Roberto; Scarselli, Marco; Longoni, Biancamaria
Triple Diagnosis of Attention-Deficit/Hyperactivity Disorder with Coexisting Bipolar and Alcohol Use Disorders: Clinical Aspects and Pharmacological Treatments 1-gen-2023 Weiss, Francesco; Tidona, Simone; Carli, Marco; Perugi, Giulio; Scarselli, Marco
Valproate and lithium: Old drugs for new pharmacological approaches in brain tumors? 1-gen-2023 Natale, G.; Fini, E.; Calabro, P. F.; Carli, M.; Scarselli, M.; Bocci, G.
A 5-Year Study of Lithium and Valproic Acid Drug Monitoring in Patients with Bipolar Disorders in an Italian Clinical Center 1-gen-2022 Carli, Marco; Risaliti, Eleonora; Francomano, Mena; Kolachalam, Shivakumar; Longoni, Biancamaria; Bocci, Guido; Maggio, Roberto; Scarselli, Marco
GPCRs in Intracellular Compartments: New Targets for Drug Discovery 1-gen-2022 Fasciani, Irene; Carli, Marco; Petragnano, Francesco; Colaianni, Francesco; Aloisi, Gabriella; Maggio, Roberto; Scarselli, Marco; Rossi, Mario
Interaction of the preferential D3 agonist (+)PHNO with dopamine D3-D2 receptor heterodimers and diverse classes of monoamine receptor: relevance for PET imaging 1-gen-2022 Petragnano, Francesco; Fasciani, Irene; Mannoury la Cour, Clotilde; di Cara, Benjamin; Aloisi, Gabriella; Carli, Marco; Kolachalam, Shivakumar; Rossi, Mario; Marampon, Francesco; Scarselli, Marco; Millan, Mark J; Maggio, Roberto
Atypical antipsychotics and metabolic syndrome: From molecular mechanisms to clinical differences 1-gen-2021 Carli, M.; Kolachalam, S.; Longoni, B.; Pintaudi, A.; Baldini, M.; Aringhieri, S.; Fasciani, I.; Annibale, P.; Maggio, R.; Scarselli, M.
Determination of G-protein–coupled receptor oligomerization by molecular brightness analyses in single cells 1-gen-2021 Isbilir, A.; Serfling, R.; Moller, J.; Thomas, R.; De Faveri, C.; Zabel, U.; Scarselli, M.; Beck-Sickinger, A. G.; Bock, A.; Coin, I.; Lohse, M. J.; Annibale, P.
Influence of substance use disorder on treatment retention of adult-attention-deficit/hyperactive disorder patients. A 5-year follow-up study 1-gen-2021 Pallucchini, A.; Carli, M.; Maremmani, A. G. I.; Scarselli, M.; Perugi, G.; Maremmani, I.
Integration and spatial organization of signaling by g protein-coupled receptor homo-and heterodimers 1-gen-2021 Maggio, R.; Fasciani, I.; Carli, M.; Petragnano, F.; Marampon, F.; Rossi, M.; Scarselli, M.
Is adult hippocampal neurogenesis really relevant for the treatment of psychiatric disorders? 1-gen-2021 Carli, Marco; Aringhieri, Stefano; Kolachalam, Shivakumar; Longoni, Biancamaria; Grenno, Giovanna; Rossi, Mario; Gemignani, Angelo; Fornai, Francesco; Maggio, Roberto; Scarselli, Marco
Symptomatological variants and related clinical features in adult attention deficit hyperactive disorder 1-gen-2021 Pallucchini, A.; Carli, M.; Scarselli, M.; Maremmani, I.; Perugi, G.
β-Cells Different Vulnerability to the Parkinsonian Neurotoxins Rotenone, 1-Methyl-4-phenylpyridinium (MPP+) and 6-Hydroxydopamine (6-OHDA) 1-gen-2021 Carli, M.; Vaglini, F.; Risaliti, E.; Citi, G.; Masini, M.; Kolachalam, S.; Maggio, R.; Corsini, G. U.; Novelli, M.; De Tata, V.; Scarselli, M.